Cargando…
Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro
Interferon regulatory factor 8 (Irf8) is a transcription factor that negatively regulates osteoclast differentiation and Irf8 global knockout (Irf8 (−/−)) mice have been shown to have reduced bone volume resulting from increased osteoclast numbers. However, detailed analysis of the functions of Irf8...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461233/ https://www.ncbi.nlm.nih.gov/pubmed/27502007 http://dx.doi.org/10.1007/s10616-016-0013-z |
_version_ | 1783242297011339264 |
---|---|
author | Saito, Emi Suzuki, Dai Kurotaki, Daisuke Mochizuki, Ayako Manome, Yoko Suzawa, Tetsuo Toyoshima, Yoichi Ichikawa, Takahiro Funatsu, Takahiro Inoue, Tomio Takami, Masamichi Tamura, Tomohiko Inagaki, Katsunori Kamijo, Ryutaro |
author_facet | Saito, Emi Suzuki, Dai Kurotaki, Daisuke Mochizuki, Ayako Manome, Yoko Suzawa, Tetsuo Toyoshima, Yoichi Ichikawa, Takahiro Funatsu, Takahiro Inoue, Tomio Takami, Masamichi Tamura, Tomohiko Inagaki, Katsunori Kamijo, Ryutaro |
author_sort | Saito, Emi |
collection | PubMed |
description | Interferon regulatory factor 8 (Irf8) is a transcription factor that negatively regulates osteoclast differentiation and Irf8 global knockout (Irf8 (−/−)) mice have been shown to have reduced bone volume resulting from increased osteoclast numbers. However, detailed analysis of the functions of Irf8 in osteoclast precursors with a monocyte/macrophage linage is difficult, because the population and properties of hematopoietic cells in Irf8 (−/−) mice are severely altered. Therefore, to clearly elucidate the functions of Irf8 during osteoclastogenesis, we established myeloid cell-specific Irf8 conditional knockout (Irf8 (fl/fl) ;Lyz2 (cre/+)) mice. We found that trabecular bone volume in the Irf8 (fl/fl) ;Lyz2 (cre/+) mice was not significantly affected, while exposure to M-CSF and RANKL significantly increased TRAP activity in vitro in osteoclasts that underwent osteoclastogenesis from bone marrow-derived macrophages (BMMs) induced from bone marrow cells (BMCs) of those mice by addition of M-CSF. Our results also showed that expression of Irf8 mRNA and protein in BMMs obtained from Irf8 (fl/fl) ;Lyz2 (cre/+) mice and cultured with M-CSF was reduced. These findings predicted that Lyz2/Lyz2-cre expression is induced when BMCs differentiate into BMMs in cultures with M-CSF. In osteoclast differentiation cultures, Lyz2 was gradually increased by M-CSF during the first 3 days of culture, then rapidly decreased by the addition of RANKL with M-CSF during the next 3 days. Furthermore, BMCs differentiated into osteoclasts while maintaining a low level of Lyz2 expression when cultured simultaneously with both M-CSF and RANKL from the initiation of culture. These findings suggest that Lyz2-cre expression is induced along with differentiation to BMMs by BMCs obtained from Irf8 (fl/fl) ;Lyz2 (cre/+) mice and cultured with M-CSF. In addition, Irf8 was down-regulated by activation of the cre/loxP recombination system in BMMs and osteoclastogenesis was accelerated. Based on our results, we propose the existence in vivo of a new lineage of osteoclast precursors among BMCs, which differentiate into osteoclasts without up-regulation of Lyz2 expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10616-016-0013-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5461233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-54612332017-06-19 Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro Saito, Emi Suzuki, Dai Kurotaki, Daisuke Mochizuki, Ayako Manome, Yoko Suzawa, Tetsuo Toyoshima, Yoichi Ichikawa, Takahiro Funatsu, Takahiro Inoue, Tomio Takami, Masamichi Tamura, Tomohiko Inagaki, Katsunori Kamijo, Ryutaro Cytotechnology Original Article Interferon regulatory factor 8 (Irf8) is a transcription factor that negatively regulates osteoclast differentiation and Irf8 global knockout (Irf8 (−/−)) mice have been shown to have reduced bone volume resulting from increased osteoclast numbers. However, detailed analysis of the functions of Irf8 in osteoclast precursors with a monocyte/macrophage linage is difficult, because the population and properties of hematopoietic cells in Irf8 (−/−) mice are severely altered. Therefore, to clearly elucidate the functions of Irf8 during osteoclastogenesis, we established myeloid cell-specific Irf8 conditional knockout (Irf8 (fl/fl) ;Lyz2 (cre/+)) mice. We found that trabecular bone volume in the Irf8 (fl/fl) ;Lyz2 (cre/+) mice was not significantly affected, while exposure to M-CSF and RANKL significantly increased TRAP activity in vitro in osteoclasts that underwent osteoclastogenesis from bone marrow-derived macrophages (BMMs) induced from bone marrow cells (BMCs) of those mice by addition of M-CSF. Our results also showed that expression of Irf8 mRNA and protein in BMMs obtained from Irf8 (fl/fl) ;Lyz2 (cre/+) mice and cultured with M-CSF was reduced. These findings predicted that Lyz2/Lyz2-cre expression is induced when BMCs differentiate into BMMs in cultures with M-CSF. In osteoclast differentiation cultures, Lyz2 was gradually increased by M-CSF during the first 3 days of culture, then rapidly decreased by the addition of RANKL with M-CSF during the next 3 days. Furthermore, BMCs differentiated into osteoclasts while maintaining a low level of Lyz2 expression when cultured simultaneously with both M-CSF and RANKL from the initiation of culture. These findings suggest that Lyz2-cre expression is induced along with differentiation to BMMs by BMCs obtained from Irf8 (fl/fl) ;Lyz2 (cre/+) mice and cultured with M-CSF. In addition, Irf8 was down-regulated by activation of the cre/loxP recombination system in BMMs and osteoclastogenesis was accelerated. Based on our results, we propose the existence in vivo of a new lineage of osteoclast precursors among BMCs, which differentiate into osteoclasts without up-regulation of Lyz2 expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10616-016-0013-z) contains supplementary material, which is available to authorized users. Springer Netherlands 2016-08-08 2017-06 /pmc/articles/PMC5461233/ /pubmed/27502007 http://dx.doi.org/10.1007/s10616-016-0013-z Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Saito, Emi Suzuki, Dai Kurotaki, Daisuke Mochizuki, Ayako Manome, Yoko Suzawa, Tetsuo Toyoshima, Yoichi Ichikawa, Takahiro Funatsu, Takahiro Inoue, Tomio Takami, Masamichi Tamura, Tomohiko Inagaki, Katsunori Kamijo, Ryutaro Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro |
title | Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro |
title_full | Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro |
title_fullStr | Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro |
title_full_unstemmed | Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro |
title_short | Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro |
title_sort | down-regulation of irf8 by lyz2-cre/loxp accelerates osteoclast differentiation in vitro |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461233/ https://www.ncbi.nlm.nih.gov/pubmed/27502007 http://dx.doi.org/10.1007/s10616-016-0013-z |
work_keys_str_mv | AT saitoemi downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT suzukidai downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT kurotakidaisuke downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT mochizukiayako downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT manomeyoko downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT suzawatetsuo downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT toyoshimayoichi downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT ichikawatakahiro downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT funatsutakahiro downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT inouetomio downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT takamimasamichi downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT tamuratomohiko downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT inagakikatsunori downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro AT kamijoryutaro downregulationofirf8bylyz2creloxpacceleratesosteoclastdifferentiationinvitro |